Atlas Trials

Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

RecordFirmDate
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) (NCT03210714)National Cancer Institute (NCI)2018-06-05
Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) (NCT03213652)National Cancer Institute (NCI)2018-04-17
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) (NCT03233204)National Cancer Institute (NCI)2017-09-14
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial) (NCT03213704)National Cancer Institute (NCI)2017-08-23
Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas (NCT02304458)National Cancer Institute (NCI)2015-03-30

Track Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor automatically

Every clearance here is in the API, with alerts when new ones post.